The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa ...
PrEP and PEP are important HIV prevention tools that hospitalists should understand and discuss with patients during hospital ...
HIV treatment has been improved and simplified significantly over the years, yet a small fraction of people living with HIV ...
President Cyril Ramaphosa is expected to launch the roll out of the lifesaving HIV prevention injectable medicine, Lenacapavir, later this week.
Gilead Sciences is maintained at 'Hold' as the HIV franchise drives growth, but the oncology pipeline requires further ...
Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 11:00 AM EDTCompany ParticipantsDaniel O'Day - Chairman ...
The abrupt closure of USAID has disrupted life-saving HIV/AIDS programs globally, sparking fears of setbacks in health ...
Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South ...
The HIV market offers opportunities in unmet needs, R&D advancements, and long-acting treatments in the 7MM, focusing on innovative products and strategic partnerships to capture modest growth from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results